The final guidance provides
information on the implementation of the new statutory provisions
described in #1 in the Supporting Statement and in the final
guidance, including a description of the types of safety labeling
changes that ordinarily might be required under the new
legislation; how the Food and Drug Administration plans to
determine what constitutes new safety information; the procedures
involved in requiring safety labeling changes; and enforcement of
the requirements for safety labeling changed.
The adjustments to the
currently approved burden hours of 824 are based on the latest
data. The new burden hours are 1,880 total hours. This is a renewal
of information collection without any program changes.
$141,950,000
No
No
No
No
No
Uncollected
Ila Mizrachi 301 796-7726
ila.mizrachi@fda.hhs.gov
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.